523 related articles for article (PubMed ID: 24858274)
21. Molecular Biomarkers and Their Implications for the Early Diagnosis of Selected Neurodegenerative Diseases.
Doroszkiewicz J; Groblewska M; Mroczko B
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563001
[TBL] [Abstract][Full Text] [Related]
22. miRNAs Identify Shared Pathways in Alzheimer's and Parkinson's Diseases.
Sadlon A; Takousis P; Alexopoulos P; Evangelou E; Prokopenko I; Perneczky R
Trends Mol Med; 2019 Aug; 25(8):662-672. PubMed ID: 31221572
[TBL] [Abstract][Full Text] [Related]
23. A Sex Perspective in Neurodegenerative Diseases: microRNAs as Possible Peripheral Biomarkers.
Piscopo P; Bellenghi M; Manzini V; Crestini A; Pontecorvi G; Corbo M; Ortona E; Carè A; Confaloni A
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922607
[TBL] [Abstract][Full Text] [Related]
24. Ghrelin and Neurodegenerative Disorders-a Review.
Shi L; Du X; Jiang H; Xie J
Mol Neurobiol; 2017 Mar; 54(2):1144-1155. PubMed ID: 26809582
[TBL] [Abstract][Full Text] [Related]
25. MicroRNAs in Neurodegenerative Diseases.
Quinlan S; Kenny A; Medina M; Engel T; Jimenez-Mateos EM
Int Rev Cell Mol Biol; 2017; 334():309-343. PubMed ID: 28838542
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA Alteration, Application as Biomarkers, and Therapeutic Approaches in Neurodegenerative Diseases.
Nguyen TPN; Kumar M; Fedele E; Bonanno G; Bonifacino T
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563107
[TBL] [Abstract][Full Text] [Related]
27. Understanding the Involvement of microRNAs in Mitochondrial Dysfunction and Their Role as Potential Biomarkers and Therapeutic Targets in Parkinson's Disease.
Tryphena KP; Anuradha U; Kumar R; Rajan S; Srivastava S; Singh SB; Khatri DK
J Alzheimers Dis; 2023; 94(s1):S187-S202. PubMed ID: 35848027
[TBL] [Abstract][Full Text] [Related]
28. The role of microRNAs in neurodegenerative diseases: a review.
Li S; Lei Z; Sun T
Cell Biol Toxicol; 2023 Feb; 39(1):53-83. PubMed ID: 36125599
[TBL] [Abstract][Full Text] [Related]
29. Shared mechanisms of neurodegeneration in Alzheimer's disease and Parkinson's disease.
Xie A; Gao J; Xu L; Meng D
Biomed Res Int; 2014; 2014():648740. PubMed ID: 24900975
[TBL] [Abstract][Full Text] [Related]
30. miRNAs: Key Players in Neurodegenerative Disorders and Epilepsy.
Karnati HK; Panigrahi MK; Gutti RK; Greig NH; Tamargo IA
J Alzheimers Dis; 2015; 48(3):563-80. PubMed ID: 26402105
[TBL] [Abstract][Full Text] [Related]
31. The Immune System and Neuroinflammation as Potential Sources of Blood-Based Biomarkers for Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease.
Clark LF; Kodadek T
ACS Chem Neurosci; 2016 May; 7(5):520-7. PubMed ID: 27046268
[TBL] [Abstract][Full Text] [Related]
32. Biomarkers in Neurodegenerative Diseases.
Jeromin A; Bowser R
Adv Neurobiol; 2017; 15():491-528. PubMed ID: 28674995
[TBL] [Abstract][Full Text] [Related]
33. The role of synaptic biomarkers in the spectrum of neurodegenerative diseases.
Mazzucchi S; Palermo G; Campese N; Galgani A; Della Vecchia A; Vergallo A; Siciliano G; Ceravolo R; Hampel H; Baldacci F
Expert Rev Proteomics; 2020; 17(7-8):543-559. PubMed ID: 33028119
[TBL] [Abstract][Full Text] [Related]
34. Biosensor approaches on the diagnosis of neurodegenerative diseases: Sensing the past to the future.
Karaboğa MNS; Sezgintürk MK
J Pharm Biomed Anal; 2022 Feb; 209():114479. PubMed ID: 34861607
[TBL] [Abstract][Full Text] [Related]
35. Role of triggering receptor expressed on myeloid cells 2 (TREM2) in neurodegenerative dementias.
Shafi S; Singh A; Ibrahim AM; Alhajri N; Abu Izneid T; Pottoo FH
Eur J Neurosci; 2021 May; 53(10):3294-3310. PubMed ID: 33786894
[TBL] [Abstract][Full Text] [Related]
36. MicroRNAs Dysregulation and Mitochondrial Dysfunction in Neurodegenerative Diseases.
Catanesi M; d'Angelo M; Tupone MG; Benedetti E; Giordano A; Castelli V; Cimini A
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825273
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic and Therapeutic Potential of Exosomal MicroRNAs for Neurodegenerative Diseases.
He M; Zhang HN; Tang ZC; Gao SG
Neural Plast; 2021; 2021():8884642. PubMed ID: 34054944
[TBL] [Abstract][Full Text] [Related]
38. Genetic architecture of sporadic frontotemporal dementia and overlap with Alzheimer's and Parkinson's diseases.
Ferrari R; Wang Y; Vandrovcova J; Guelfi S; Witeolar A; Karch CM; Schork AJ; Fan CC; Brewer JB; ; ; ; Momeni P; Schellenberg GD; Dillon WP; Sugrue LP; Hess CP; Yokoyama JS; Bonham LW; Rabinovici GD; Miller BL; Andreassen OA; Dale AM; Hardy J; Desikan RS
J Neurol Neurosurg Psychiatry; 2017 Feb; 88(2):152-164. PubMed ID: 27899424
[TBL] [Abstract][Full Text] [Related]
39. Emergence of exosomal miRNAs as a diagnostic biomarker for Alzheimer's disease.
Van Giau V; An SS
J Neurol Sci; 2016 Jan; 360():141-52. PubMed ID: 26723991
[TBL] [Abstract][Full Text] [Related]
40. Selective distribution and dynamic modulation of miRNAs in the synapse and its possible role in Alzheimer's Disease.
Garza-Manero S; Pichardo-Casas I; Arias C; Vaca L; Zepeda A
Brain Res; 2014 Oct; 1584():80-93. PubMed ID: 24355599
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
